Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Non-cash Items (2024 - 2025)

Evommune (EVMN) has disclosed Non-cash Items for 2 consecutive years, with $54.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 9216.75% to $54.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.5 million, a 9216.75% increase, with the full-year FY2025 number at $54.5 million, up 9216.75% from a year prior.
  • Non-cash Items was $54.5 million for Q4 2025 at Evommune, up from $6.9 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $54.5 million in Q4 2025 to a low of $585000.0 in Q4 2024.